Intelligence Β· Clinical Pipeline

Vera Therapeutics Pipeline

All ClinicalTrials.gov programs at Vera Therapeutics β€” phase, modality, and trial IDs.

Programs
4

Quick answer

Vera Therapeutics has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. CYP2C19 genotyping

    Vera Therapeutics

    Myocardial Infarction

    approved gene therapy completed

    1 trial
  2. Experimental: Hyperslim

    Vera Therapeutics

    Venous Thromboembolism (VTE)

    approved other active

    1 trial
  3. Peginterferon alfa-2a

    Vera Therapeutics

    Hepatitis B, Chronic

    approved small molecule active

    1 trial
  4. Pregabalin

    Vera Therapeutics

    Pain, Postoperative

    approved small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Vera Therapeutics have?

4 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs